| THF–water hydrate crystallization: an experimental investigation S Devarakonda, A Groysman, AS Myerson Journal of Crystal Growth 204 (4), 525-538, 1999 | 122 | 1999 |
| Untitled US Patent US2,009, 0 | 54* | |
| Growth kinetics of single crystal sII hydrates: Elimination of mass and heat transfer effects P Bollavaram, S Devarakonda, MS Selim, ED Sloan Jr Annals of the New York Academy of Sciences 912 (1), 533-543, 2000 | 52 | 2000 |
| Impact of ultrasonic energy on the crystallization of dextrose monohydrate S Devarakonda, JMB Evans, AS Myerson Crystal growth & design 3 (5), 741-746, 2003 | 38 | 2003 |
| Impact of ultrasonic energy on the flow crystallization of dextrose monohydrate S Devarakonda, JMB Evans, AS Myerson Crystal growth & design 4 (4), 687-690, 2004 | 30 | 2004 |
| Non-benzodiazepine hypnotic compositions S Gore, S Agrawal, A Upadhye, S Rangineni, S Bommareddy, S Gade, ... US Patent App. 11/553,342, 2007 | 25 | 2007 |
| Ab initio structure determination of anhydrous sodium alendronate from laboratory powder x-ray diffraction data M Asnani, K Vyas, A Bhattacharya, S Devarakonda, S Chakraborty, ... Journal of pharmaceutical sciences 98 (6), 2113-2121, 2009 | 19 | 2009 |
| Preparation of lenalidomide SN Devarakonda, SR Yarraguntla, VK Mudapaka, R Kadaboina, V Murki, ... US Patent App. 12/921,613, 2011 | 14 | 2011 |
| Desvenlafaxine succinate monohydrate N Venu, BR Sreekanth, T Ram, S Devarakonda Acta Crystallographica Section C: Crystal Structure Communications 64 (5 …, 2008 | 13 | 2008 |
| Molecular dynamics study of the interactions of ice inhibitors on the ice {001} surface S Devarakonda, JMB Evans, AY Lee, AS Myerson Langmuir 20 (13), 5353-5357, 2004 | 12 | 2004 |
| Polytypism in desvenlafaxine succinate monohydrate NK Duggirala, SL Kanniah, VK Muppidi, R Thaimattam, S Devarakonda CrystEngComm 11 (6), 989-992, 2009 | 9 | 2009 |
| Process for preparing voriconazole V Sundaram, VBR Uppala, SP Akundi, V Muvva, V Chitta, A Donthula, ... US Patent App. 11/721,697, 2008 | 9 | 2008 |
| Process for preparing (2R, 3S/2S, 3R)-2-(2, 4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1, 2, 4-triazol-1-yl) butan-2-ol V Sundaram, VBR Uppala, SP Akundi, V Muvva, V Chitta, A Donthula, ... US Patent 8,039,619, 2011 | 7 | 2011 |
| Aripiprazole co-crystals SN Devarakonda, K Vyas, SR Bommareddy, PR Padi, B Raghupathy US patent no. US20090054455 A 1, 2009, 2007 | 7 | 2007 |
| Solid forms of pemetrexed RV Palle, SM Nariyam, VB Patel, RRS Vinjamuri, SN Devarakonda, ... US Patent 8,507,508, 2013 | 6 | 2013 |
| Solifenacin compositions P Kharwade, M Snehalatha, AV Patil, NB Vishwanathan, I Bhushan, ... US Patent App. 12/595,290, 2010 | 4 | 2010 |
| Amorphous valganciclovir hydrochloride SN Devarakonda, SR Yerraguntla, V Nalivela, AK Tummala US Patent App. 12/607,187, 2010 | 4 | 2010 |
| Amorphous valganciclovir hydrochloride SN Devarakonda, SR Yerraguntla, V Nalivela, AK Tummala US Patent App. 12/204,949, 2009 | 3 | 2009 |
| Imatinib mesylate SN Devarakonda, M Asnani, MS Nariyam, AK Tummala, VK Mudapaka, ... US Patent App. 12/529,671, 2010 | 2 | 2010 |
| Zafirlukast compositions S Rangineni, H Bhagwatwar, S Devarakonda, S Agarwal US Patent App. 11/671,480, 2007 | 1 | 2007 |
Allan S MyersonProfessor of the Practice of Chemical Engineering ,Massachusetts Institute of TechnologyVerified email at mit.edu
